Acticor Biotech (XPAR:ALACT) Total Liabilities : €13.93 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech Total Liabilities?

Acticor Biotech's Total Liabilities for the quarter that ended in Jun. 2023 was €13.93 Mil.

Acticor Biotech's quarterly Total Liabilities increased from Jun. 2022 (€7.01 Mil) to Dec. 2022 (€15.19 Mil) but then declined from Dec. 2022 (€15.19 Mil) to Jun. 2023 (€13.93 Mil).

Acticor Biotech's annual Total Liabilities declined from Dec. 2020 (€9.30 Mil) to Dec. 2021 (€6.86 Mil) but then increased from Dec. 2021 (€6.86 Mil) to Dec. 2022 (€15.19 Mil).

Acticor Biotech Total Liabilities Historical Data

The historical data trend for Acticor Biotech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acticor Biotech Total Liabilities Chart

Acticor Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Liabilities

Get a 7-Day Free Trial

5.17

6.37

9.30

6.86

15.19

Acticor Biotech Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Liabilities	Get a 7-Day Free Trial				9.06	6.86	7.01	15.19	13.93

Acticor Biotech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Acticor Biotech's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	6.701	+	(7.062	+	1.367
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0.056)
	=	15.19

Total Liabilities	=	Total Assets (A: Dec. 2022 )	-	Total Equity (A: Dec. 2022 )
	=	12.943	-	-2.243
	=	15.19

Acticor Biotech's Total Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8.606	+	(4.342	+	0.901
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0.085)
	=	13.93

Total Liabilities	=	Total Assets (Q: Jun. 2023 )	-	Total Equity (Q: Jun. 2023 )
	=	14.302	-	0.368
	=	13.93

Acticor Biotech Total Liabilities Related Terms

Thank you for viewing the detailed overview of Acticor Biotech's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Acticor Biotech (XPAR:ALACT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

7V7:Germany

Address

82 Avenue du Maine, Wojo Building, Paris, FRA, 75014

Website

https://www.acticor-biotech.com

Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Acticor Biotech (XPAR:ALACT) Headlines

No Headlines